Horizon Therapeutics Public Limited Company

BMV:HZNP N Stock Report

Market Cap: Mex$486.6b

Horizon Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of HZNP N?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,0290.00132%
State or Government104,8640.0458%
Individual Insiders379,2340.166%
General Public9,585,3024.19%
Hedge Funds12,726,9005.56%
Institutions206,195,23990%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 59.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.41%
The Vanguard Group, Inc.
21,544,524Mex$45.8b-0.04%0.05%
6.48%
BlackRock, Inc.
14,841,177Mex$31.5b-0.42%0.04%
5.56%
Pentwater Capital Management LP
12,726,900Mex$27.0b109%19.7%
3.11%
UBS O'Connor LLC
7,124,969Mex$15.1b63.7%35.35%
3.06%
Avoro Capital Advisors LLC
7,000,000Mex$14.9b0%12.34%
2.62%
HBK Investments L.P.
6,000,000Mex$12.7b1.69%74.91%
2.3%
State Street Global Advisors, Inc.
5,274,052Mex$11.2b2.97%0.03%
2.3%
JPMorgan Chase & Co, Brokerage and Securities Investments
5,271,269Mex$11.2b-0.71%0.44%
2.06%
D. E. Shaw & Co., L.P.
4,717,646Mex$10.0b28.1%0.98%
1.97%
Millennium International Management LP
4,520,705Mex$9.6b4.94%102.1%
1.95%
Citadel Advisors LLC
4,463,101Mex$9.5b12.2%0.67%
1.85%
Norges Bank Investment Management
4,245,009Mex$9.0b0.69%0.05%
1.83%
Davidson Kempner Capital Management LP
4,193,486Mex$8.9b-6.36%19.16%
1.77%
Millennium Management LLC
4,058,491Mex$8.6b-5.79%0.52%
1.51%
Renaissance Technologies LLC
3,448,749Mex$7.3b2.38%0.6%
1.5%
Adage Capital Management, L.P.
3,427,925Mex$7.3b14.5%0.89%
1.44%
Geode Capital Management, LLC
3,301,561Mex$7.0b0.73%0.04%
1.44%
Soros Fund Management LLC
3,291,801Mex$7.0b0%14.36%
1.31%
Fidelity International Ltd
3,003,963Mex$6.4b1.24%0.17%
1.17%
Franklin Resources, Inc.
2,690,055Mex$5.7b11.3%0.13%
1.07%
Morgan Stanley, Investment Banking and Brokerage Investments
2,458,323Mex$5.2b70.8%0.05%
0.99%
Deutsche Asset & Wealth Management
2,274,568Mex$4.8b14.7%0.15%
0.99%
Westchester Capital Management, LLC
2,257,464Mex$4.8b10.5%13.76%
0.93%
Taconic Capital Advisors L.P.
2,130,000Mex$4.5b5.06%24.08%
0.89%
BNY Mellon Asset Management
2,039,156Mex$4.3b-3.96%0.05%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/09 00:37
End of Day Share Price 2023/10/05 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Horizon Therapeutics Public Limited Company is covered by 24 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Donald EllisAvondale Partners
Gary NachmanBMO Capital Markets Equity Research
Jason Matthew GerberryBofA Global Research